Order Article Reprints

Chosidow S, Fantin B, Nicolas I, Mascary J-B, Chau F, Bordeau V, Verdier M-C, Rocheteau P, Guérin F, Cattoir V, et al. Synergistic Activity of Pep16, a Promising New Antibacterial Pseudopeptide against Multidrug-Resistant Organisms, in Combination with Colistin against Multidrug-Resistant Escherichia coli, In Vitro and in a Murine Peritonitis Model. Antibiotics. 2023; 12(1):81. https://doi.org/10.3390/antibiotics12010081

Chosidow, Samuel, Bruno Fantin, Irène Nicolas, Jean-Baptiste Mascary, Françoise Chau, Valérie Bordeau, Marie-Clemence Verdier, Pierre Rocheteau, Francois Guérin, Vincent Cattoir, and et al. 2023. "Synergistic Activity of Pep16, a Promising New Antibacterial Pseudopeptide against Multidrug-Resistant Organisms, in Combination with Colistin against Multidrug-Resistant Escherichia coli, In Vitro and in a Murine Peritonitis Model" Antibiotics 12, no. 1: 81. https://doi.org/10.3390/antibiotics12010081

Chosidow, S., Fantin, B., Nicolas, I., Mascary, J.-B., Chau, F., Bordeau, V., Verdier, M.-C., Rocheteau, P., Guérin, F., Cattoir, V., & de Lastours, V. (2023). Synergistic Activity of Pep16, a Promising New Antibacterial Pseudopeptide against Multidrug-Resistant Organisms, in Combination with Colistin against Multidrug-Resistant Escherichia coli, In Vitro and in a Murine Peritonitis Model. Antibiotics, 12(1), 81. https://doi.org/10.3390/antibiotics12010081